See more : Renesas Electronics Corporation (RNECF) Income Statement Analysis – Financial Results
Complete financial analysis of BIO-key International, Inc. (BKYI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of BIO-key International, Inc., a leading company in the Security & Protection Services industry within the Industrials sector.
You may be interested
- Zhejiang Jianye Chemical Co., Ltd. (603948.SS) Income Statement Analysis – Financial Results
- Algernon Pharmaceuticals Inc. (AGN.CN) Income Statement Analysis – Financial Results
- Stratec SE (SBS.DE) Income Statement Analysis – Financial Results
- Housing and Urban Development Corporation Limited (HUDCO.NS) Income Statement Analysis – Financial Results
- Italia Independent Group S.p.A. (IIG.MI) Income Statement Analysis – Financial Results
BIO-key International, Inc. (BKYI)
About BIO-key International, Inc.
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.75M | 7.02M | 5.11M | 2.84M | 2.27M | 4.04M | 6.30M | 2.98M | 5.26M | 4.01M | 1.99M | 3.84M | 3.51M | 3.52M | 2.36M | 12.88M | 9.99M | 15.19M | 14.23M | 5.56M | 524.10K | 155.40K | 0.00 | 1.00 | 157.97K | 384.58K | 464.17K | 32.00K |
| Cost of Revenue | 6.32M | 2.04M | 1.67M | 794.83K | 2.46M | 4.16M | 6.48M | 729.68K | 1.28M | 748.75K | 387.03K | 571.73K | 810.46K | 559.14K | 504.24K | 1.74M | 1.78M | 3.40M | 3.84M | 2.06M | 89.08K | 2.72K | 0.00 | -137.30K | -33.19K | 1.05M | 390.24K | 14.88K |
| Gross Profit | 1.43M | 4.98M | 3.44M | 2.04M | -193.72K | -119.65K | -181.32K | 2.25M | 3.98M | 3.26M | 1.60M | 3.26M | 2.70M | 2.96M | 1.85M | 11.14M | 8.20M | 11.80M | 10.38M | 3.49M | 435.02K | 152.68K | 0.00 | 137.30K | 191.16K | -669.97K | 73.93K | 17.13K |
| Gross Profit Ratio | 18.46% | 70.95% | 67.29% | 71.98% | -8.54% | -2.96% | -2.88% | 75.48% | 75.68% | 81.31% | 80.51% | 85.10% | 76.90% | 84.12% | 78.61% | 86.52% | 82.13% | 77.64% | 72.98% | 62.86% | 83.00% | 98.25% | 0.00% | 13,730,400.00% | 121.01% | -174.21% | 15.93% | 53.52% |
| Research & Development | 2.39M | 3.25M | 2.36M | 1.40M | 1.33M | 1.42M | 1.66M | 2.01M | 1.56M | 1.63M | 1.34M | 947.37K | 1.12M | 1.06M | 927.24K | 4.49M | 4.99M | 6.51M | 6.85M | 2.98M | 1.04M | 1.08M | 947.93K | 1.14M | 856.69K | 1.57M | 563.05K | 386.61K |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.33M | 0.00 | 0.00 | 1.88M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.24M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.86M | 9.64M | 6.03M | 5.85M | 5.04M | 5.33M | 5.68M | 4.44M | 4.12M | 3.67M | 2.78M | 2.29M | 3.04M | 3.11M | 3.38M | 6.55M | 8.57M | 10.31M | 11.82M | 7.10M | 2.12M | 1.93M | 1.32M | 1.85M | 2.15M | 3.31M | 2.30M | 422.68K |
| Other Expenses | 0.00 | 452.82K | 60.00K | -340.82K | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 137.30K | 485.79K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 10.26M | 13.35M | 8.44M | 6.90M | 6.37M | 6.75M | 7.34M | 6.45M | 5.68M | 5.30M | 4.12M | 3.24M | 4.15M | 4.16M | 4.31M | 11.04M | 13.57M | 16.83M | 18.67M | 10.08M | 3.16M | 3.01M | 2.27M | 3.13M | 3.49M | 4.88M | 2.86M | 809.29K |
| Cost & Expenses | 16.58M | 15.39M | 10.12M | 7.70M | 8.83M | 10.91M | 13.82M | 7.18M | 6.96M | 6.04M | 4.51M | 3.81M | 4.96M | 4.72M | 4.81M | 12.78M | 15.35M | 20.22M | 22.51M | 12.14M | 3.24M | 3.01M | 2.27M | 2.99M | 3.46M | 5.94M | 3.25M | 824.17K |
| Interest Income | 11.53K | 233.00 | 4.08K | 30.65K | 154.00 | 80.00 | 27.00 | 30.00 | 14.00 | 7.00 | 7.00 | 7.00 | 95.03K | 241.42K | 165.71K | 1.34K | 3.10K | 0.00 | 35.96K | 66.82K | 4.15K | 0.00 | 0.00 | 0.00 | 0.00 | 99.88K | 0.00 | 4.29K |
| Interest Expense | 218.27K | 29.95K | 18.00K | 4.34M | 1.07M | 80.00 | 27.00 | 30.00 | 161.06K | 7.00 | 136.48K | 24.63K | 411.53K | 711.35K | 89.80K | 92.52K | 832.46K | 5.73M | 6.55M | 667.01K | 1.11M | 1.16M | 317.63K | 141.34K | 0.00 | 496.48K | 0.00 | 35.61K |
| Depreciation & Amortization | 590.14K | 546.01K | 514.07K | 426.91K | 1.14M | 1.74M | 1.58M | 62.64K | 56.60K | 68.80K | 49.58K | 39.87K | 42.73K | 32.82K | 50.77K | 854.24K | 1.46M | 4.14M | 5.88M | 637.12K | 6.39K | -1.12K | 31.94K | 137.30K | 485.79K | 633.26K | 103.62K | 20.39K |
| EBITDA | -7.85M | -11.37M | -4.53M | -4.90M | -12.38M | -5.13M | -2.70M | -4.14M | -1.61M | -1.83M | -2.39M | 67.77K | -1.32M | 94.40K | -2.61M | 1.13M | -3.91M | -887.95K | -4.44M | -4.55M | -2.71M | -2.86M | -2.23M | -2.85M | -2.82M | -4.92M | -2.68M | -700.00K |
| EBITDA Ratio | -101.19% | -119.17% | -97.72% | -170.32% | -289.39% | -129.94% | -42.82% | -139.47% | -31.15% | -49.19% | -124.48% | 1.77% | -36.63% | -62.13% | -89.52% | 6.02% | -45.37% | -3.73% | -123.49% | -105.96% | -517.85% | -1,839.96% | 0.00% | -285,180,800.00% | -1,783.25% | -1,279.69% | -577.95% | -2,411.80% |
| Operating Income | -8.83M | -9.69M | -5.00M | -4.86M | -6.56M | -6.87M | -4.28M | -4.20M | -1.70M | -2.04M | -2.52M | 27.89K | -1.45M | -1.20M | -2.46M | 98.19K | -5.36M | -5.03M | -8.29M | -6.58M | -2.72M | -2.86M | -2.27M | -2.99M | -3.30M | -5.55M | -2.79M | -792.17K |
| Operating Income Ratio | -113.82% | -138.03% | -97.80% | -171.40% | -289.40% | -169.83% | -67.83% | -141.17% | -32.22% | -50.90% | -126.97% | 0.73% | -41.46% | -34.09% | -104.22% | 0.76% | -53.71% | -33.10% | -58.26% | -118.42% | -519.07% | -1,839.24% | 0.00% | -298,911,100.00% | -2,090.76% | -1,444.36% | -600.27% | -2,475.53% |
| Total Other Income/Expenses | 170.47K | -2.01M | -123.93K | -4.47M | -1.07M | 80.00 | 27.00 | 12.12K | -160.13K | 157.26K | -57.67K | -24.62K | -416.49K | 550.23K | -206.08K | 86.34K | -204.35K | -6.05M | 4.61M | 1.81M | -1.11M | -1.16M | -317.63K | 0.00 | 0.00 | 0.00 | 0.00 | 56.56K |
| Income Before Tax | -8.66M | -10.23M | -5.07M | -9.67M | -14.59M | -6.87M | -4.28M | -4.19M | -1.86M | -1.88M | -2.58M | 3.27K | -1.90B | -306.79M | 4.69B | 119.18K | -1.06M | -11.08M | 6.87M | -7.24M | -3.83M | -4.02M | -2.58M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -111.62% | -145.74% | -99.05% | -341.02% | -643.37% | -169.83% | -67.83% | -140.76% | -35.28% | -46.98% | -129.88% | 0.09% | -54,081.28% | -8,714.59% | 199,108.51% | 0.93% | -10.58% | -72.93% | 48.29% | -130.21% | -730.03% | -2,586.87% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -134.01K | 511.27K | -496.07K | 3.92M | 64.28K | 160.00 | 0.00 | 912.00 | 912.00 | 1.71K | 2.81K | 7.00 | 442.99K | -893.22K | -7.15M | -20.99K | -4.31M | 6.05M | -8.65M | 655.48K | 0.00 | 1.16M | -300.25K | 141.34K | 125.58K | 396.60K | -192.45K | 31.32K |
| Net Income | -8.52M | -10.74M | -4.57M | -13.59M | -14.65M | -6.87M | -4.28M | -4.19M | -1.86M | -1.88M | -2.58M | 3.27K | -1.90M | -306.79K | 4.69M | 119.18K | -1.06M | -11.08M | 358.07K | -7.24M | -3.83M | -4.02M | -2.28M | -3.13M | -3.43M | -5.95M | -2.59M | -823.49K |
| Net Income Ratio | -109.89% | -153.02% | -89.35% | -479.07% | -646.21% | -169.83% | -67.83% | -140.79% | -35.30% | -47.02% | -130.02% | 0.09% | -54.08% | -8.71% | 199.11% | 0.93% | -10.58% | -72.93% | 2.52% | -130.21% | -730.03% | -2,586.87% | 0.00% | -313,045,300.00% | -2,170.26% | -1,547.48% | -558.81% | -2,573.40% |
| EPS | -15.21 | -23.87 | -10.56 | -52.04 | -148.35 | -4.73 | -5.15 | -6.00 | -2.70 | -3.06 | -5.40 | 0.01 | -4.66 | -0.76 | 11.52 | -9.60 | -3.46 | -42.35 | -17.28 | -39.92 | -41.87 | -58.35 | -40.12 | -62.68 | -79.23 | -152.46 | -71.04 | -16.04 |
| EPS Diluted | -15.21 | -23.87 | -10.56 | -52.04 | -148.35 | -4.73 | -5.15 | -6.00 | -2.70 | -3.06 | -5.40 | 0.01 | -4.66 | -0.76 | 11.52 | -9.60 | -3.46 | -42.35 | -23.04 | -39.92 | -41.87 | -58.35 | -40.12 | -62.68 | -79.23 | -152.46 | -71.04 | -16.04 |
| Weighted Avg Shares Out | 560.28K | 450.04K | 432.87K | 261.15K | 98.78K | 1.45M | 829.80K | 698.39K | 687.85K | 615.07K | 478.08K | 407.06K | 407.06K | 405.73K | 377.88K | 334.16K | 305.69K | 261.63K | 233.27K | 181.28K | 91.37K | 68.89K | 56.92K | 49.94K | 43.27K | 39.03K | 36.51K | 51.34K |
| Weighted Avg Shares Out (Dil) | 560.28K | 450.04K | 432.87K | 261.15K | 98.78K | 1.45M | 829.80K | 698.39K | 687.85K | 615.07K | 478.08K | 407.06K | 407.06K | 405.73K | 377.88K | 334.16K | 305.69K | 261.63K | 271.07K | 181.28K | 91.37K | 68.89K | 56.92K | 49.94K | 43.27K | 39.03K | 36.51K | 51.34K |
BIO-key International, Inc. (BKYI) Q2 2024 Earnings Call Transcript
BIO-key International, Inc. (NASDAQ:BKYI ) Q2 2024 Earnings Conference Call August 15, 2024 10:00 AM ET Company Participants Bill Jones - Investor Relations Mike DePasquale - Chairman and Chief Executive Officer Cecilia Welch - Chief Financial Officer Conference Call Participants...
BIO-key's PortalGuard Identity and Access Management Solution and Identity-Bound Biometrics Are Now Available on the Amazon Web Services (AWS) Marketplace
$BKYI BIO-key's PortalGuard Identity Access Management Solution & Identity-Bound Biometrics Are Now Available on the Amazon Web Services (AWS) Marketplace
BIO-key Reports Reduced Net Loss and Cash Used in Operations on Lower Q2'24 Revenues; Hosts Investor Call Thu. Aug. 15th at 10am ET
HOLMDEL, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its...
Identity and Access Management Solutions Provider BIO-key Hosts Q2 Investor Call Thursday, August 15th at 10am ET
HOLMDEL, N.J., Aug. 12, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q2 2024 investor call Thursday, August 15th at 10 a.m.
Williamsburg, VA Advances Zero Trust Initiative for City Infrastructure and Data with BIO-key Identity-Bound Biometrics
Williamsburg, Virginia Advances Zero Trust Initiative (Cyber Security) for City's Software Infrastructure and Data with BIO-key's Identity-Bound Biometrics
BIO-key International, Inc. (BKYI) Q1 2024 Earnings Call Transcript
BIO-key International, Inc. (NASDAQ:BKYI ) Q1 2024 Earnings Conference Call June 18, 2024 10:00 AM ET Corporate Participants Bill Jones - Investor Relations Mike DePasquale - Chairman and Chief Executive Officer Ceci Welch - Chief Financial Officer Jim Sullivan -...
Identity, Access Management and Cybersecurity Solutions Provider BIO-key International Hosts Q1 Investor Call Tues., June 18th at 10am ET
HOLMDEL, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q1 2024 investor call Tuesday, June 18th at 10 a.m.
Identity and Access Management Solutions Provider BIO-key to Participate in Fireside Chat at the Maxim Group Virtual Tech Conference, Tues. June 4th at 9:00am ET
Identity, Access Management Solutions Provider BIO-key to Participate in Fireside Chat at the Maxim Group Virtual Tech Conference, Tues. June 4th at 9am ET
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq
WALL, N.J., May 24, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), announced today that on May 22, 2024, it received a...
BIO-key Expects to File Audited 2023 Results on Form 10-K and Report Q1 2024 Results and Host an Investor Call Next Week
HOLMDEL, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, today announced that it...
Source: https://incomestatements.info
Category: Stock Reports